The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis
about
Recombinant dense granular protein (GRA5) for detection of human toxoplasmosis by Western blot.DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in miceMic1-3 Knockout Toxoplasma gondii is a good candidate for a vaccine against T. gondii-induced abortion in sheepThe extracellular matrix protein mindin as a novel adjuvant elicits stronger immune responses for rBAG1, rSRS4 and rSRS9 antigens of Toxoplasma gondii in BALB/c miceResearch advances in microneme protein 3 of Toxoplasma gondii.Peptide microarray analysis of in silico-predicted epitopes for serological diagnosis of Toxoplasma gondii infection in humans.Protecting babies: vaccine strategies to prevent foetopathy in Neospora caninum-infected cattle.Toxoplasmosis - An update.Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB/c Mice.Induction of Protective Immunity against Toxoplasmosis in BALB/c Mice Vaccinated with Toxoplasma gondii Rhoptry-1.Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis.Protective immune response in BALB/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondiiProtective effect of DNA-mediated immunization with liposome-encapsulated GRA4 against infection of Toxoplasma gondiiVaccines against Toxoplasma gondii: challenges and opportunities.Current status of toxoplasmosis vaccine development.Identification of a TNF-α inducer MIC3 originating from the microneme of non-cystogenic, virulent Toxoplasma gondii.Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice.A DNA vaccine encoding a fatty acid-binding protein of Clonorchis sinensis induces protective immune response in Sprague-Dawley rats.Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.Effect of Nigella sativa oil on experimental toxoplasmosis.MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum.Recombinant ROP2, ROP4, GRA4 and SAG1 antigen-cocktails as possible tools for immunoprophylaxis of toxoplasmosis: what's next?Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice.Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice.A guide to in silico vaccine discovery for eukaryotic pathogens.Depletion of CD25⁺ cells during acute toxoplasmosis does not significantly increase mortality in Swiss OF1 mice.Latex agglutination using the periplasmic proteins antigen of Brucella melitensis is a successful, rapid, and specific serodiagnostic test for ovine brucellosis.Evaluation of the Protective Effect of Deoxyribonucleic Acid Vaccines Encoding Granule Antigen 2 and 5 Against Acute Toxoplasmosis in BALB/c Mice.Immunization With a DNA Vaccine Cocktail Encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 Genes Protects Mice Against Chronic ToxoplasmosisRecent progress in microneme-based vaccines development againstGRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondiiEvaluation of Toxoplasma gondii-recombinant dense granular protein (GRA2) for serodiagnosis by western blot
P2860
Q33759998-D51AF06F-1EA1-4A36-9118-7F250D2F92D1Q33769376-09E3997D-A2AC-40D3-84C1-1361B714E3BEQ33834785-C9390E07-2993-407B-9B11-388289880B7BQ34037687-D126285E-3987-4BD3-B9B3-1BBD25C91EF0Q35875290-8BCC3EE0-1076-48E9-B4F6-77A21D4D0B93Q36017737-BA0CE095-0531-4D38-BD34-FE1A46C8EBF2Q36379495-0A7E02ED-630F-47AA-9BAA-3F497EC6FDD9Q36671583-E7B154D5-5529-4BB5-BC2E-2413B87949DBQ36843269-CD425477-6CD5-4977-8598-90DD6A661E59Q36943560-A6EC4AB4-EEE5-4C5C-829D-A0FA45A89AD4Q36952854-6F6B0DAC-2FF9-440D-BB4C-1ADDF61D47D8Q37119395-02D8FF32-E45A-4307-B6DF-3BAAE9B055FDQ37248425-78C08342-6D47-4C67-A1C2-15FCC172367BQ37476759-EF53ED70-253A-4F16-B36A-52A127A3B294Q37503262-0A61635A-6151-4163-BBEB-5811621B992DQ37522385-902093EB-AD7E-4F54-9E46-7071C5E2B8C2Q38740356-BB81C7C4-26C8-4DE5-9EC4-3F78DAA63F7BQ40311968-789FD608-ECDE-4B58-BECA-0F33A7881AA0Q40498945-EF9D2DB0-1C17-498E-8A88-73D8CCD299AFQ40962264-57570E82-A34F-4B1B-898B-6099016B0EAAQ41124154-45666796-0708-4DBE-A609-EB579DBA2A2CQ41476002-CA682C0A-0240-41BE-A842-94D1A17AB30CQ43886809-A4E832FF-D955-422A-9D02-0844AB737B61Q44108100-267C4717-CCBA-40D6-AB6F-43C571158830Q45003975-97D8A95A-EC5D-48CC-AFA4-AB30C4DEC83FQ48616399-0F943C3F-58B3-4F60-AEA0-B0560AE7E71FQ50318601-FFFC523C-B5E8-4E8F-BA3F-82557F1EDDD5Q50884140-E52EBE4E-B779-4C59-AEED-230B5364092CQ56567289-8C1240AA-40F5-4B0B-85B3-D242DF692383Q57177851-8BC23B8F-7356-462B-9077-E30F5F329338Q57203120-2A63D2E5-79DD-4CB5-BDDB-21FD43297B31Q57269731-C1623023-D31F-4261-9EEC-32FE8FD68963
P2860
The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
The MIC3 gene of Toxoplasma go ...... andidate against toxoplasmosis
@ast
The MIC3 gene of Toxoplasma go ...... andidate against toxoplasmosis
@en
type
label
The MIC3 gene of Toxoplasma go ...... andidate against toxoplasmosis
@ast
The MIC3 gene of Toxoplasma go ...... andidate against toxoplasmosis
@en
prefLabel
The MIC3 gene of Toxoplasma go ...... andidate against toxoplasmosis
@ast
The MIC3 gene of Toxoplasma go ...... andidate against toxoplasmosis
@en
P2093
P2860
P1476
The MIC3 gene of Toxoplasma go ...... andidate against toxoplasmosis
@en
P2093
Christine Collin
Dalila Sekkai
Daniel Bout
Marie-Noëlle Mévélec
P2860
P304
P356
10.1128/IAI.71.11.6222-6228.2003
P407
P577
2003-11-01T00:00:00Z